98 studies found for:    Open Studies | "Carcinoma, Ductal, Breast"
Show Display Options
Rank Status Study
21 Recruiting Phase 0 Biodistribution of Novel Imaging for Resectable Pancreatic Cancer
Condition: Pancreatic Ductal Adenocarcinoma
Intervention: Drug: PTP-01
22 Recruiting Plasma Biomarkers P-DAC, V1
Condition: Pancreatic Ductal Adenocarcinoma
Intervention:
23 Recruiting A Phase II Study of Neoadjuvant FOLFIRINOX
Condition: Resectable Pancreatic Ductal Adenocarcinoma
Intervention: Drug: FOLFIRINOX
24 Recruiting Phase IV Trial to Evaluate Breast Brachytherapy Using the Mammosite-Ml®
Conditions: Breast Cancer;   Ductal Carcinoma in Situ
Intervention: Device: Mammosite ML
25 Not yet recruiting A Phase II Study of siG12D LODER in Combination With Chemotherapy in Patients With Unresectable Locally Advanced Pancreatic Cancer
Conditions: Pancreatic Ductal Adenocarcinoma;   Pancreatic Cancer
Interventions: Drug: siG12D LODER;   Drug: Gemcitabine or FOLFIRINOX
26 Not yet recruiting Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas
Conditions: Lung Adenocarcinoma;   Breast Adenocarcinoma;   Pancreatic Ductal Adenocarcinoma
Intervention: Other: their will be no intervention in any of the groups, the study is retrospective
27 Recruiting Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
Conditions: Colorectal Cancer;   Gastric Adenocarcinoma;   Esophageal Cancer;   Hepatocellular Carcinoma;   Non-small Cell Lung Cancer;   Small Cell Lung Cancer;   Ovarian Epithelial Cancer;   Breast Cancer;   Hormone-refractory Prostate Cancer;   Pancreatic Ductal Adenocarcinoma;   Head and Neck Cancers- Squamous Cell;   Renal Cell Cancer;   Bladder Cancer
Intervention: Drug: IMMU-132
28 Not yet recruiting Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer
Conditions: Invasive Breast Cancer (Stage I-III);   Ductal Carcinoma in Situ;   Lobular Carcinoma in Situ;   Lobular Carcinoma;   Fatigue Related to Cancer Treatment
Interventions: Drug: Naltrexone;   Drug: Sugar Pill
29 Unknown  Diagnostic Study of Early Breast Cancer Using Ultrasound
Condition: Ductal Carcinoma In-situ
Intervention: Drug: Perflutren lipid microsphere
30 Recruiting Study to Assess Perfusion and Patient Satisfaction in Nipple-Areola Mastectomy With Immediate Reconstruction
Conditions: Ductal Carcinoma in Situ (DCIS);   Clinical Stage I Breast Cancer;   Prophylactic Mastectomy
Interventions: Procedure: Inframammary Fold Incision or Lateral Radial Incision;   Procedure: Lateral Radial Incision;   Procedure: Inframammary Fold Incision;   Device: Laser-assisted fluorescence angiography
31 Recruiting Intraoperative Gamma Camera for Breast Cancer Surgery
Conditions: Breast Cancer;   Ductal Carcinoma in Situ
Intervention: Device: SLN procedure (CarolIReS camera)
32 Recruiting Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ
Condition: Breast Cancer
Interventions: Drug: letrozole;   Procedure: adjuvant radiation;   Procedure: dynamic contrast-enhanced magnetic resonance imaging;   Procedure: adjuvant hormonal therapy;   Procedure: therapeutic conventional surgery
33 Recruiting Contrast-Enhanced MRI in Women With Ductal Breast Carcinoma in Situ and in Healthy Volunteers
Condition: Breast Cancer
Intervention: Procedure: contrast-enhanced magnetic resonance imaging
34 Recruiting Evaluation of the Diagnostic Performance of MRI±Biopsy to Optimize Resection of Ductal Carcinoma In Situ (DCIS) Breast Cancer
Condition: Breast Cancer
Intervention: Procedure: MRI±biopsy
35 Recruiting Nipple-Areola Complex (NAC) Irradiation After Nipple-Sparing Mastectomy and Reconstruction
Conditions: Breast Cancer;   Ductal Carcinoma
Interventions: Procedure: Nipple Area Complex-Sparing Mastectomy;   Radiation: Nipple Area Complex Irradiation;   Procedure: Breast Reconstruction;   Procedure: Axillary Dissection or Sentinel Node Biopsy (SNB);   Drug: Chemotherapy
36 Recruiting Oncologic Impact of Splenectomy-omitting Radical Pancreatectomy in Well-selected Left-sided Pancreatic Cancer
Conditions: Left-sided Pancreatic Cancer;   Ductal Adenocarcinoma
Interventions: Procedure: Radical Antegrade Modular Pancreatectomy with Splenectomy;   Procedure: Radical Antegrade Modular Pancreatectomy without splenectomy
37 Recruiting Targeted Intraoperative Radiotherapy United States (TARGIT-US) Registry Trial
Conditions: Malignant Neoplasm of Breast;   Breast Diseases;   Ductal Breast Carcinoma
Intervention: Radiation: Intraoperative radiation therapy (IORT)
38 Recruiting Lumpectomy Followed By Intraoperative Electron Radiation Therapy (IOERT)
Conditions: Invasive Ductal Breast Cancer;   Carcinoma Breast Stage I
Intervention: Radiation: Intraoperative Electron Radiotherapy
39 Not yet recruiting A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)
Conditions: Tubular Breast Cancer Stage II;   Tubular Breast Cancer Stage III;   Mucinous Breast Cancer Stage II;   Breast Cancer Female NOS;   Invasive Ductal Breast Cancer;   HER2 Positive Breast Cancer;   Inflammatory Breast Cancer
Interventions: Drug: non-pegylated liposomal doxorubicin;   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Epirubicin;   Drug: Cyclophosphamide;   Drug: Pertuzumab;   Drug: Trastuzumab;   Drug: Ferric carboxymaltose
40 Unknown  The Significance of MRI in the Development of Diagnostics and Treatment of Breast Cancer
Condition: Mammary Ductal Carcinoma
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years